Filing Details
- Accession Number:
- 0000789132-14-000165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-23 21:32:10
- Reporting Period:
- 2014-10-21
- Filing Date:
- 2014-10-23
- Accepted Time:
- 2014-10-23 21:32:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 789132 | Spectranetics Corp | SPNC | Electromedical & Electrotherapeutic Apparatus (3845) | 840997049 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559939 | Michael Robert Fuchs | 9965 Federal Drive Colorado Springs CO 80921 | Sr. Vp, Global Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Spnc Common Stock | Acquisiton | 2014-10-21 | 6,000 | $13.69 | 6,990 | No | 4 | M | Direct | |
| Spnc Common Stock | Disposition | 2014-10-21 | 6,000 | $28.10 | 990 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Spnc Common Stock | SPNC Stock Option Grant | Disposition | 2014-10-21 | 6,000 | $0.00 | 6,000 | $13.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 44,000 | 2022-11-02 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to Mr. Fuchs' 10b5-1 plan dated March 10, 2014
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.10 to $28.135, inclusive. The reporting person undertakes to provide to The Spectranetics Corporation, any security holder of The Spectranetics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- Grant date 11/2/2012. Options are on a 4 year, 100% vesting schedule; 25% vest on 11/2/2013; 6.25% vests each calendar quarter thereafter. 100% fully vested on 11/2/2016. Options expire at the end of 10 years or on 11/2/2022.
Billionaire Hedge Funds
